Intracordal injection therapy for vocal fold scarring: Steroid versus basic fibroblast growth factor.

Nozawa M, Takahashi S, Kanazawa T, Kurakami K, Hasegawa T, Hirosaki M, Kamitomai M, Komazawa D, Konomi U, Ito M, Watanabe Y

Open source

DOI
10.1002/lio2.881
Published
2022 Oct
Container
Laryngoscope investigative otolaryngology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/lio2.881,
  title = {Intracordal injection therapy for vocal fold scarring: Steroid versus basic fibroblast growth factor.},
  author = {Nozawa M and Takahashi S and Kanazawa T and Kurakami K and Hasegawa T and Hirosaki M and Kamitomai M and Komazawa D and Konomi U and Ito M and Watanabe Y},
  year = {2022},
  journal = {Laryngoscope investigative otolaryngology},
  doi = {10.1002/lio2.881},
  url = {https://doi.org/10.1002/lio2.881}
}

RIS

TY  - JOUR
TI  - Intracordal injection therapy for vocal fold scarring: Steroid versus basic fibroblast growth factor.
AU  - Nozawa M
AU  - Takahashi S
AU  - Kanazawa T
AU  - Kurakami K
AU  - Hasegawa T
AU  - Hirosaki M
AU  - Kamitomai M
AU  - Komazawa D
AU  - Konomi U
AU  - Ito M
AU  - Watanabe Y
PY  - 2022
JO  - Laryngoscope investigative otolaryngology
DO  - 10.1002/lio2.881
UR  - https://doi.org/10.1002/lio2.881
ER  - 

APA

M, N., S, T., T, K., K, K., T, H., M, H., M, K., D, K., U, K., M, I., & Y, W. (2022). Intracordal injection therapy for vocal fold scarring: Steroid versus basic fibroblast growth factor.. Laryngoscope investigative otolaryngology. https://doi.org/10.1002/lio2.881

Source records